Kaya17

KAYA17 Products

KAYA17 has a complete Point of Need testing solution for COVID-19 with the following features:

ACCURATE

98% Sensitivity
98% Specificity

RAPID

Sample to Results
in 15 Minutes

CONVENIENT

Only Saliva Test in
Ultra-Portable Kit

COST-EFFECTIVE

Needs Minimal
Training

GROUP TESTING

Quick testing
for busy places

One KAYA17 reader can run 30 tests per hour at a testing site and can be scaled up to 300 tests per hour with ten readers, thus making it an ideal candidate for rapid testing at airports, resorts, events, cruise lines, stations, schools, workplaces, and hospitals.

Future KAYA17 Products

The KAYA 17 platform technology has a wide range of applications. With a minor change to the reagents, rapid Point-of-Care tests can be developed for other medical diagnostic targets. No change will be required for the cartridge and reader. This allows the technology to be used in the rapid diagnosis of several other diseases and conditions as well, with the same level of accuracy and efficiency.

Cervical Cancer: Test validated with patient sample at All India Institute of Medical Science (AIIMS).
Food Diagnosis: Test validated for E. Coli, Salmonella, Listeria
Allergy Testing: Under development.


Other Tests: The KAYA17 technology base goes beyond COVID-19 testing, using the same platform. The following tests are candidates for future development:

US and other Markets: Hepatitis B, UTI, Cardiac Markers, Influenza A & B, Nora Virus, Strep Throat, Staph Infection, Sepsis
Developing Countries: Cervical Cancers, UTI, Hepatitis B & C, HIV, Food bacteria (E. Coli, Salmonella, Listeria), Water Testing, Dengue, Chikungunya

KAYA17 on CNBC Advancements Program